Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
AI-assisted medical literature monitoring platform for pharmacovigilance literature screening and case intake.
DrugCard, founded in 2019 and registered in Tallinn, Estonia, provides a literature-monitoring platform for pharmacovigilance teams. It screens local and global medical literature — including non-English local journals — for adverse reaction mentions, using automated translation and AI-assisted screening to surface potential individual case safety reports for human review. The company reports hosting on ISO/IEC 27001- and SOC 2-certified AWS infrastructure; Atlas does not treat inherited infrastructure certifications as vendor-held certifications.
50% — Partial coverage. Coverage score — how completely Atlas documents DrugCard across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, CRO / CDMO, Pharmacovigilance
Adverse Event Detection, Natural Language Processing
Private, Founded 2019
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?